EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Novel multifunctional tacrine–donepezil hybrids against Alzheimer's disease: Design synthesis and bioactivity studies

Gülşah Bayraktar, Manuela Bartolini, Maria Laura Bolognesi, Mumin Alper Erdoğan, Güliz Armağan, Ece Bayır, Aylin Şendemir, Donatella Bagetta, Stefano Alcaro, Vildan Alptüzün

Archiv der Pharmazie · 2024

DOI: 10.1002/ardp.202300575 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Gülşah Bayraktar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ege University, Izmir, Turkey. Hauptthemen laut MEDLINE: Tacrine, Donepezil, Cholinesterase Inhibitors, Alzheimer Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ege University Research Foundation, Research Grants from Ege University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of tacrine–donepezil hybrids were synthesized as potential multifunctional anti‐Alzheimer's disease (AD) compounds. For this purpose, tacrine and the benzylpiperidine moiety of donepezil were fused with a hydrazone group to achieve a small library of tacrine–donepezil hybrids. In agreement with the design, all compounds showed inhibitory activity toward both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) with IC 50 values in the low micromolar range. Kinetic studies on the most potent cholinesterase (ChE) inhibitors within the series showed a mixed‐type inhibition mechanism on both enzymes. Also, the docking studies indicated that the compounds inhibit ChEs by dual binding site (DBS) interactions. Notably, tacrine–donepezil hybrids also exhibited significant neuroprotection against H 2 O 2 ‐induced cell death in a differentiated human neuroblastoma (SH‐SY5Y) cell line at concentrations close to their IC 50 values on ChEs and showed high to medium blood–brain barrier (BBB) permeability on human cerebral microvascular endothelial cells (HBEC‐5i). Besides, the compounds do not cause remarkable toxicity in a human hepatocellular carcinoma cell line (HepG2) and SH‐SY5Y cells. Additionally, the compounds were predicted to also have good bioavailability. Among the tested compounds, H4 , H16 , H17 , and H24 stand out with their biological profile. Taken together, the proposed novel tacrine–donepezil scaffold represents a promising starting point for the development of novel anti‐ChE multifunctional agents against AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrineDonepezilCholinesterase InhibitorsAlzheimer DiseaseButyrylcholinesteraseAcetylcholinesteraseDrug DesignBlood-Brain BarrierNeuroprotective AgentsMolecular Docking SimulationHumansStructure-Activity RelationshipMolecular StructureDose-Response Relationship, DrugHep G2 CellsCell Line, Tumor

Stichwörter der Autor:innen

AChE inhibitionBBB permeabilityBChE inhibitionneuroprotectiontacrine–donepezil hybrid

Substanzen

TacrineDonepezilCholinesterase InhibitorsButyrylcholinesteraseAcetylcholinesteraseNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ege University, Izmir, Turkey.
  • Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Bologna, Italy.
  • Department of Physiology, Katip Celebi University School of Medicine, Izmir, Turkey.
  • Department of Biochemistry, Faculty of Pharmacy, Ege University, Izmir, Turkey.
  • Ege University Central Research Test and Analysis Laboratory Application and Research Center (EGE-MATAL), Ege University, Izmir, Turkey.
  • Department of Bioengineering, Faculty of Engineering, Ege University, Izmir, Turkey.

Förderung

  • Ege University Research Foundation
  • Research Grants from Ege University

Zitieren

APA

Bayraktar, G., Bartolini, M., Bolognesi, M. L., Erdoğan, M. A., Armağan, G., Bayır, E., Şendemir, A., Bagetta, D., Alcaro, S., & Alptüzün, V. (2024). Novel multifunctional tacrine–donepezil hybrids against Alzheimer's disease: Design synthesis and bioactivity studies. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202300575

Vancouver

Bayraktar G, Bartolini M, Bolognesi ML, Erdoğan MA, Armağan G, Bayır E, et al. Novel multifunctional tacrine–donepezil hybrids against Alzheimer's disease: Design synthesis and bioactivity studies. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202300575

BibTeX
@article{Bayraktar2024,
  author = {Bayraktar, Gülşah and Bartolini, Manuela and Bolognesi, Maria Laura and Erdoğan, Mumin Alper and Armağan, Güliz and Bayır, Ece and Şendemir, Aylin and Bagetta, Donatella and Alcaro, Stefano and Alptüzün, Vildan},
  title = {Novel multifunctional tacrine–donepezil hybrids against Alzheimer's disease: Design synthesis and bioactivity studies},
  journal = {Archiv der Pharmazie},
  year = {2024},
  doi = {10.1002/ardp.202300575}
}
Kostenlos starten →